






































J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 2 , N O . 5 , 2 0 0 9
© 2 0 0 9 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / 0 9 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 0 8 . 1 2 . 0 2 4I S T O R I C A L P E R S P E C T I V E
oronary Flow Reserve and Pharmacologic
tress Perfusion Imaging
eginnings and Evolution

































harmacologic stress for myocardial perfusion
maging fell out of my first experiment mea-
uring coronary flow during progressive steno-
is in 1972, published in 1974 (1). The arte-
iogram and flowmeter dramatically showed
he 3 fundamental physiological concepts un-
erlying all stress myocardial perfusion imag-
ng. The first was the concept of coronary flow
eserve as a physiological measure of stenosis
everity separately from anatomical or dimen-
ional severity and shown in Figure 1. The
econd was the correlation of this physiological
oronary function with arteriographic stenosis
imensions and demonstration of critical ste-
osis that lowers resting flow. The third was
harmacologic arteriolar vasodilation as the
tressor for stimulating maximal coronary flow
hat, in these early studies, was contrast media.
uman Coronary Physiology
he relevance of the initial animal studies to
umans was an open question then. Human
oronary physiology and stenosis fluid dy-
amics were not well known. To test the
oncept of coronary flow reserve and phar-
acologic stress imaging in humans, we
njected intracoronary macroaggregated al-
umin labeled with technetium 99 (Tc-
rom the Department of Medicine, TheWeatherhead PET Center
or Preventing and Reversing Atherosclerosis, University of Texas
edical School at Houston and Memorial Hermann Hospital,
ouston, Texas.vanuscript received November 30, 2008; December July 16, 2009.AA) during the hyperemia immediately
fter intracoronary contrast media for coro-
ary arteriography. Planar images of hyper-
mic Tc-MAA in patients with coronary
rtery stenosis showed corresponding re-
ional perfusion defects, confirming the con-
epts of coronary flow reserve and pharma-
ologic stress imaging in coronary artery
isease (CAD) (2).
harmacologic Stress: Dipyridamole
ith the basic concepts established, an al-
ernative to intracoronary contrast media was
eeded, with some literature suggesting in-
ravenous dipyridamole as a possibility (3,4).
t was the basis for a series of integrated
xperimental and human studies entitled
Noninvasive Assessment of Coronary Ste-
oses by Myocardial Imaging During Coro-
ary Vasodilation: Part I Through Part
III,” published in the American Journal of
ardiology (5–12) under the creative editor-
hip of Simon Dack.
The first 3 parts of this series addressed
ipyridamole perfusion imaging, including the
rst human dipyridamole perfusion study, done
n myself, using thallium-201 at the start of
he clinical cases. However, these initial studies
lso revealed the limitations of planar imaging
ompared to direct flow measurements for
ssessing stenosis severity. The fourth study
howed the power of experimental post-
ortem imaging of short-axis sections of the
eart after dipyridamole hyperemia and intra-
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665ion tomography (PET) and the remaining reports
f the series (9,10,12,13).
ET
n an intense 3-week collaboration with Heinrich
chelbert, I flew a group of chronically instrumented
nimals to the University of California at Los Angeles
or the first study of dipyridamole PET perfusion
maging. It showed dipyridamole-induced myocardial
erfusion defects for 47% diameter coronary stenosis,
ith the severity of the defects proportional to quan-
itative arteriographic severity. As the last experiment
nished, the scanner went down with a blown power
upply. An all-night data analysis and writing session
ade the deadline and won the von Hevesy Prize for
esearch in 1978 (9).
tenosis Pressure-Flow Characteristics
n retrospect, at this point a very important issue
lipped by me because of my intense focus on
tenosis. My pressure-flow data with quantitative
rteriographic dimension of stenosis fit classic qua-
ratic equations described in the fluid dynamic
iterature (14) at resting conditions. At maximum
ow, the data failed to fit the same equations that
orked at rest. This discrepancy was deeply dis-
urbing for 1 year because it called into question
Figure 1. Coronary Flow at Resting Baseline and at Maximum A
Perfusion Imaging
Adapted with permission from Gould et al. (1).verything done before—data quality, the physio- togical and fluid dynamic concepts—nightmares of
ailure. Finally, I realized that the data at maximum
yperemic flow fit the classic fluid dynamic equa-
ions only if the stenosis dimensions were worse
han at baseline resting flow conditions.
low-Mediated Vasodilation
ow could the stenosis at maximum hyperemic
ow be worse with a fixed rigid mechanical con-
triction on the coronary artery? The answer was on
he arteriograms done with pressure flow data,
hown in Figure 2. At maximum hyperemic flow,
he normal coronary artery on each side of the
tenosis dilated substantially so that the percent
tenosis was worse, thereby explaining more severe
ressure flow characteristics during hyperemia com-
ared to resting baseline conditions, as published in
978 (15).
This first demonstration of flow-mediated epi-
ardial coronary vasodilation was interesting be-
ause the mechanism was unknown. However, hav-
ng tied together the concepts of coronary flow
eserve, pharmacologic stress, and the pressure–
ow–anatomy relations of coronary artery stenosis,
headed for the University of Texas at Houston as
hief of Cardiology to establish the first dedicated
linical cardiac PET center, and failed to pursue
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666orted the mechanism of flow-mediated coronary
asodilation as endothelial acetylcholine.
linical Cardiac PET
n Texas, my PET technical team, under the direction
f Nizar Mullani, Ross Hartz, and David Bristow,
esigned and built the first multiring PET scanner for
maging the entire heart in 1 acquisition without
ndexed repositioning for each tomographic slice. As
his scanner was completed, before the cyclotron
uilding was finished, we did the first large clinical
rial of generator-produced rubidium-82 compared
ith quantitative coronary arteriography (12,13).
Dipyridamole PET perfusion imaging was also
dentifying early asymptomatic CAD, raising the
ifficult issue of management not found in tradi-
ional paradigms of cardiovascular medicine at the
ime. However, cardiac PET perfusion imaging was
ncorporated into a trial of extremely low-fat, com-
lete intravenous alimentation in patients with
noperable CAD. Dipyridamole PET showed
maller stress-induced perfusion defects immedi-
tely after 90 days of low-fat intravenous alimenta-
ion compared with baseline PET before treatment
r with PET at 60 days after treatment was ended
17). We hypothesized that this short-term im-
rovement in myocardial perfusion was caused by
mproved endothelial function, later confirmed by
thers.
The Lifestyle Heart Trial (18) confirmed im-
Figure 2. Coronary Arteriogram and Arterial Diameter at Restin
Instrumented Animal Model
The radiopaque sphere is a steel ball bearing 3.18 mm in diameter
Flowmeter wires and an external additional reference bar are also s
indicate maximum ﬂow. Adapted with permission from Gould et alroved myocardial perfusion by PET imaging in mAD patients after 1 year on a low-fat diet; PET
maging further confirmed improved myocardial
erfusion in association with and predictive of
educed coronary events after 5 years of combined
igorous lifestyle and lipid-lowering drugs (19,20).
dditional experimental studies defined relative
nd absolute coronary flow reserve as the physio-
ogical basis for quantitative PET perfusion imag-
ng (21).
heWeatherhead PET Center for Preventing
nd Reversing Atherosclerosis
he technology has evolved to PET-computed
omography (CT) that has strengths but also sig-
ificant complexities and potential errors not widely
ecognized or resolved (22). Having developed so-
utions to these problems, the Weatherhead PET
enter for Preventing and Reversing Atherosclero-
is now routinely uses PET for identifying early or
dvanced CAD, for assessing its physiological se-
erity as the basis for invasive procedures or not, for
ollowing up changes in severity, and for improving
atient adherence. Quantitative PET perfusion im-
ges show the entire range of absolute flows and
oronary flow reserves of each artery down to small
ranches with single or multiple stenosis, diffuse
isease, and/or myocardial steal indicating collater-
lization, illustrated in Figure 3. Here, PET imag-
ng has become integral to and inseparable from
anagement of CAD—integrated diagnosis, treat-
seline Conditions and at Maximum Flow in a Chronically
lanted next to the coronary artery at surgery as a size reference.
. Black arrows indicate resting baseline conditions; white arrows
).g Ba
imp
eenent, and procedural guide (23–25).
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667Figure 3. PET of Myocardial Perfusion
(A) Orientation of views. Adapted with permission from Sdringola et al. (20). (B) Myocardial uptake of rubidium-82 at rest and during dipyridamole stress show-
ing relative myocardial perfusion reserve according to the color bar scale, ranging from maximum (white) in steps down to next highest (red), intermediate nor-
mal (yellow), intermediate low (green), low (blue), and lowest (black). The superimposed generic arterial map based on 1,000 PET-arteriogram correlations
shows the precision of coronary arterial distributions by PET. In the lowest panel, values for absolute coronary ﬂow reserve based on absolute myocardial perfu-
sion in ml/min/g range from normal of 4.1 to intermediate low of 2.2 to 0.9, indicating myocardial steal characterizing collateralized occluded coronary arteries.
In this example, the PET scans indicate severe diffuse disease of the left anterior descending, the left circumﬂex, and the distal posterior descending coronary
arteries with collateralized occluded diagonal and obtuse marginal branches without myocardial scar on resting images, conﬁrmed by coronary arteriogram.
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668Assessing myocardial perfusion has evolved
rom initial concepts shown by flowmeter in
xperimental models to integration with detailed
tenosis geometry to complex endothelial func-
ion to routine measurements of absolute myo-
ardial flow and flow reserve of every artery and
ranch of the coronary tree as a guide to man-
gement of CAD.
he Future
ardiovascular medicine and procedures areaging during pharmacologic coronary
vasodilatation. IV. Limits of stenosis
duced stenoses in t
of dogs. Circ Res 1r indirectly. However, few people measure or
nderstand it in humans. Artifact-free, quantita-
ive perfusion images, absolute myocardial flow in
illiliters per minute per gram, and coronary flow
eserve open profound new windows into the
eart with awaiting discoveries and clinical
pplications.
eprint requests and correspondence:Dr. K. LanceGould,
he Weatherhead PET Center, University of Texas
edical School, 6431 Fannin Street, Room 4.256MSB,
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